TTNP icon

Titan Pharmaceuticals
TTNP

Overview Fund Activity

23 hedge funds and large institutions have $759K invested in Titan Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.

Holders
23
Holders Change
+2
Holders Change %
+9.52%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
6
Closed
3
Calls
$21K
Puts
–
Net Calls
+$21K
Net Calls Change
-$24K

Top Buyers

1
TRCT
1
Tower Research Capital (TRC)
New York
$1K
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$268
3
Group One Trading
3
Group One Trading
Illinois
$237
4
PNC Financial Services Group
4
PNC Financial Services Group
Pennsylvania
$156
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$64.3K

Top Sellers

1
IA
1
IFP Advisors
Florida
$1K
2
FIA
2
FNY Investment Advisers
New York
$0
3
Millennium Management
3
Millennium Management
New York
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
UBS Group
5
UBS Group
Switzerland
$129
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
26
Concourse Financial Group Securities
Alabama
– – – –
Simplex Trading
27
Simplex Trading
Illinois
– – – –
WIM
28
Westside Investment Management
California
$0 4 – –
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
$0 61 +61 New
1
2